Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

University of Oxford launches new public awareness campaign for Neurodevelopmental Disorders

The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.

Study reveals blood stem cells can ‘remember’ inflammation

Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers

12 Oxford scientists elected Fellows of the Royal Society

Twelve renowned Oxford researchers have been elected Fellows of the Royal Society, the UK’s national academy of sciences, in recognition of their exceptional contributions to advancing scientific knowledge.

Clinical trial of ketogenic therapy for early psychosis funded by Baszucki Group

The University Oxford has received £1.17m of funding from Baszucki Group to assess the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P).

Oxford researchers develop wearable ultrasound patch for continuous pregnancy monitoring

New technology could help identify fetal complications earlier in high-risk pregnancies. Researchers at the University of Oxford and collaborators have helped develop a wearable ultrasound patch capable of continuously monitoring fetal wellbeing during pregnancy, offering a potential new approach to identifying complications earlier in high-risk pregnancies.

Expert comment: landmark plans to accelerate rare disease treatments in the UK are a welcome development

Matthew Wood, Professor of Neuroscience in the Department of Paediatrics at the University of Oxford and Director & Chief Scientific Officer of the Oxford-Harrington Rare Disease Centre, comments on new government plans to bring treatments for rare diseases a step closer.

Academy of Medical Sciences elects five Oxford researchers as new Fellows

The Academy of Medical Sciences has elected five University of Oxford biomedical and health scientists to its fellowship in 2026.

Wearable GPS data expands understanding of schistosomiasis transmission

Proximity to unsafe water strongly predicts schistosomiasis exposure, explaining sharp differences in infection and re‑infection across communities.

Statement on vaccine efforts relating to the Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo

In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) is working urgently with Oxford’s own Clinical BioManufacturing Facility and the Serum Institute of India Pvt. Ltd. (SIIPL), to rapidly produce and scale doses of our ChAdOx-based monovalent Bundibugyo Ebolavirus candidate vaccine, ChAdOx1 BDBV.

Expert Comment: the hidden mental health impacts of heatwaves

Ahead of the forecast high temperatures over the UK’s Spring Bank Holiday weekend, Dr Laurence Wainwright, Senior Departmental Lecturer at the Smith School of Enterprise & Environment and Senior Researcher in the Department of Psychiatry, outlines the unexpected risks.

3DxN - Better understanding of disease through multi-modal imaging

Engineers and healthcare scientists from the University of Oxford and the University of Cape Town, South Africa, have come together to improve technologies for diagnosing disease and furthering our understanding of fundamental processes of disease. By advancing three-dimensional imaging of tissue at the microscopic scale, tissue-based analysis of changes in gene expression, and artificial intelligence methodologies, the team aims to generate new insights from tissue samples into health and disease.

Study launched for Andes hantavirus using a pre‑approved outbreak protocol

Following the outbreak of Andes hantavirus disease on the cruise ship MV Hondius, UK universities and the UK Health Security Agency (UKHSA) have launched a new clinical study to characterise infection and disease associated with Andes hantavirus.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences hosts international workshop to advance therapeutic discovery in chondrosarcoma

Researchers, clinicians, industry partners, bone cancer charities and patients recently gathered at St Catherine’s College, University of Oxford, for the inaugural ‘Oxford Workshop on Systems Biology and Therapeutic Approaches in Chondrosarcoma’. The event brought together expertise across research and clinical care with the long-term aim to improve outcomes for patients with chondrosarcoma.

Oxford scientists devise method to speed up diagnosis of bloodstream infections

Scientists in Oxford have developed a faster way to identify the organisms causing bloodstream infections and to predict antibiotic resistance using rapid DNA sequencing, a move that could improve the care of sepsis patients in hospital and reduce unnecessary antibiotic use. Up to 245,000 people develop sepsis each year in the UK, and 48,000 die as a result.

Global study of HIV variants underscores challenges for vaccine development

The largest-ever study mapping genetic variants of HIV-1 around the world over the past 35 years shows that the regional distribution of different subtypes of the virus continues to evolve, posing a challenge to prevention and treatment efforts.

The 50th Anniversary of the Oxford Self-harm Monitoring System

Influential and impactful Oxford Self-harm Monitoring System had been in place, and continuously funded, for 50 years.

Breakthrough Oxford study moves newborn screening for SMA towards nationwide rollout

A major national study led by the University of Oxford to evaluate newborn screening for spinal muscular atrophy (SMA) has been funded by the National Institute for Health and Care Research (NIHR), marking a significant milestone towards the potential introduction of SMA screening across the UK.

Sixty Seconds with Quin Xie, Novo-Nordisk Oxford Fellow

Oxford guide to the UKRI-MRC funding terminology changes

UKRI is introducing harmonised names for translation and commercialisation funding from 2026, including updated terminology for MRC Impact Acceleration and Proof of Concept routes (previously known as MRC Gap and MRC DPFS respectively). We have developed a guide to help Oxford researchers understand what is changing, what stays the same, and which scheme may best fit their project stage.

Bodleian Libraries Update - May 2026 - Book clubs | Examination couches | Information skills workshops| Wellbeing

Load More